Shanghai Bao Pharmaceuticals Overview
- Year Founded
-
2019
- Status
-
Public
- Employees
-
364
- Stock Symbol
-
02659
- Share Price
-
$1.33
- (As of Friday Closing)
Shanghai Bao Pharmaceuticals General Information
Description
Shanghai Bao Pharmaceuticals Co Ltd is a biotechnology company with an approved product and a diverse clinical pipeline, leveraging synthetic biology technology to develop and deliver recombinant biologic drugs in China, targeting conditions with limited treatment options and complex manufacturing challenges. The company has proprietary technology platforms, supported by its chassis cell engineering technology, that combine drug design and bioprocessing capabilities. It has production lines for finished dosage forms, including injectable solutions, lyophilized powder injections, and pre-filled syringes. The group has only one reportable operating segment, which is the research, development, and commercialisation of pharmaceutical products.
Contact Information
Website
www.baopharma.comCorporate Office
- No. 28, Luoxin Road
- Baoshan District
- Shanghai, 201908
- China
Corporate Office
- No. 28, Luoxin Road
- Baoshan District
- Shanghai, 201908
- China
Shanghai Bao Pharmaceuticals Timeline
Shanghai Bao Pharmaceuticals Stock Performance
As of 13-Nov-2026, Shanghai Bao Pharmaceuticals’s stock price is $1.33. Its current market cap is $430M with 323M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.33 | $1.45 | $0.83 - $26.33 | $430M | 323M | 1.33M | -$0.19 |
Shanghai Bao Pharmaceuticals Financials Summary
As of 30-Jun-2026, Shanghai Bao Pharmaceuticals has a trailing 12-month revenue of $2.44M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 604,482 | 1,497,601 | ||
| Revenue | 2,435 | 6,835 | 858 | 980 |
| EBITDA | (47,324) | (49,827) | (46,326) | (20,065) |
| Net Income | (52,290) | (54,969) | (50,789) | (22,671) |
| Total Assets | 319,361 | 316,861 | 186,746 | 137,387 |
| Total Debt | 62,283 | 45,021 | 28,117 | 15,675 |
Shanghai Bao Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shanghai Bao Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Shanghai Bao Pharmaceuticals Patents
Shanghai Bao Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026082137-A1 | Chymotrypsinogen and use thereof | Pending | 16-Oct-2024 | ||
| EP-4744681-A1 | Target cell-targeting complex and use thereof | Pending | 16-Aug-2024 | ||
| WO-2026037175-A1 | Target cell-targeting complex and use thereof | Pending | 16-Aug-2024 | ||
| WO-2026017088-A1 | Method for reducing level of immunoglobulin g in subject | Pending | 16-Jul-2024 | ||
| EP-4740956-A1 | Pharmaceutical combination for subcutaneous administration and use thereof | Pending | 08-Feb-2024 | A61K47/68037 |
Shanghai Bao Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Shanghai Bao Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shanghai Bao Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Shanghai Bao Pharmaceuticals FAQs
-
When was Shanghai Bao Pharmaceuticals founded?
Shanghai Bao Pharmaceuticals was founded in 2019.
-
Where is Shanghai Bao Pharmaceuticals headquartered?
Shanghai Bao Pharmaceuticals is headquartered in Shanghai, China.
-
What is the size of Shanghai Bao Pharmaceuticals?
Shanghai Bao Pharmaceuticals has 364 total employees.
-
What industry is Shanghai Bao Pharmaceuticals in?
Shanghai Bao Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Shanghai Bao Pharmaceuticals a private or public company?
Shanghai Bao Pharmaceuticals is a Public company.
-
What is Shanghai Bao Pharmaceuticals’s stock symbol?
The ticker symbol for Shanghai Bao Pharmaceuticals is 02659.
-
What is the current stock price of Shanghai Bao Pharmaceuticals?
As of 13-Nov-2026 the stock price of Shanghai Bao Pharmaceuticals is $1.33.
-
What is the current market cap of Shanghai Bao Pharmaceuticals?
The current market capitalization of Shanghai Bao Pharmaceuticals is $430M.
-
What is Shanghai Bao Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Shanghai Bao Pharmaceuticals is $2.44M.
-
What is Shanghai Bao Pharmaceuticals’s annual earnings per share (EPS)?
Shanghai Bao Pharmaceuticals’s EPS for 12 months was -$0.19.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
